Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Industrial Biotechnology and Commodity Products
With over 50% of GLP-1 users discontinuing due to cost and 36% due to side effects, Nooms low and slow titration strategy could offer a more sustainable path to weight loss
Examples of these problems include chronic fatigue syndrome, fibromyalgia, multiple sclerosis, Parkinson's disease, Alzheimer's disease, depression, asthma, chronic bronchitis and other respiratory infections, viral infections, immune system disorders, liver diseases, and cancer
(PMID: 34827486) and the broader systematic review by Ho and Nation (PMID: 29733881) provide some supporting evidence from outside the affected research group
ArticlePubMed 33
US$ 27.51
US$ 28.14
US$ 26.22
US$ 23.13
US$ 25.11
US$ 25.78
